Steven Jamerson
GTD
Injury Illness
2024 CBB Stats
PTS
9.1
REB
7.1
AST
1.0
STL
1.2
BLK
0.8
ROS Projections
DNP at Gonzaga
Jamerson (illness) did not play during San Diego's 93-80 loss Wednesday at Gonzaga, USDToreros.com reports.
ANALYSIS
Jamerson enrolled at San Diego again for his senior season. Because of him physically ill during the Toreros-Gonzaga game, USD's starting lineup required at least one change then. It added Kean Webb, who logged five rebounds.
Jamerson enrolled at San Diego again for his senior season. Because of him physically ill during the Toreros-Gonzaga game, USD's starting lineup required at least one change then. It added Kean Webb, who logged five rebounds.
College Basketball Stats
Loading CBB Stats...
2024
2023
2022
2024 CBB Game Log
Loading Game Log...
2024 CBB Split Stats
Loading CBB Stats...
Toreros Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
Recent RotoWire Articles Featuring Steven Jamerson See More
Is the West Coast Conference more than just Gonzaga and St. Mary's in 2024-25? How will the new teams affect the landscape? Find out in our WCC fantasy hoops preview.
Season-long college fantasy basketball is nearing its home stretch, and Ryan Andrade is back to provide recommended pickups to help managers with their playoff pushes.
More Fantasy News
Double-double in win
Jamerson supplied 14 points (7-7 FG, 0-2 FT), 11 rebounds and two blocks over 35 minutes during Wednesday's 79-77 victory over Loyola Marymount.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Six points in first start
Jamerson produced six points (3-5 FG) and five rebounds across 19 minutes during Sunday's 88-64 loss to Stanford.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Starting Thursday
Jamerson is in the starting lineup for Thursday's game against Pepperdine.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.